omniture
健艾仕生物医药科技(杭州)有限公司

Latest News

GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation

HANGZHOU, China, June 1, 2023 /PRNewswire/ -- GenEros Biopharma Ltd. ("GenEros" or "the Company"), ...

2023-06-01 22:15 2462